eXoZymes (EXOZ) Stock Chart & Stock Price History $9.81 -0.21 (-2.10%) As of 07/11/2025 03:57 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock eXoZymes Stock Price Performance The eXoZymes (EXOZ) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 25.40%, reflecting recent market activity. As of the latest close, eXoZymes traded at $9.81 with a market cap of $82.11 million and volume of 601 shares. Receive EXOZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.63%1 Month Performance-25.40%3 Month Performance-10.00% EXOZ Stock Chart for Saturday, July, 12, 2025 EXOZ Chart by TradingView eXoZymes Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$10.02$9.81-2.10%$9.81$9.81601 shs$82.11 million07/10/2025$10.14$10.02-1.18%$10.02$10.00735 shs$83.85 million07/09/2025$10.00$10.14+1.40%$10.14$9.811,134 shs$84.87 million07/08/2025$10.18$10.00-1.77%$10.12$9.907,322 shs$83.70 million07/07/2025$9.91$10.18+2.72%$10.18$9.712,190 shs$85.21 million07/04/2025$9.91$9.91$10.01$9.691,256 shs$82.95 million07/03/2025$10.20$9.91-2.84%$10.01$9.691,256 shs$82.95 million07/02/2025$9.75$10.20+4.62%$10.24$9.602,730 shs$85.37 million07/01/2025$9.88$9.75-1.32%$9.90$9.601,335 shs$81.59 million06/30/2025$10.39$9.88-4.91%$10.45$9.5043,194 shs$82.70 million Get the Latest News and Ratings for EXOZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$9.73$10.39+6.78%$10.78$9.763,867 shs$86.96 million06/26/2025$10.24$9.73-4.98%$10.70$8.8669,125 shs$81.44 million06/25/2025$10.32$10.24-0.78%$10.27$9.595,085 shs$85.71 million06/24/2025$10.50$10.32-1.71%$10.50$9.804,707 shs$86.38 million06/23/2025$9.15$10.50+14.75%$10.60$9.5011,103 shs$87.86 million06/20/2025$12.35$9.15-25.91%$12.38$9.1551,458 shs$76.59 million06/19/2025$12.35$12.35$12.35$12.35811 shs$103.37 million06/18/2025$12.40$12.35-0.40%$12.35$12.35811 shs$103.37 million06/17/2025$12.69$12.40-2.29%$13.40$12.403,223 shs$106.19 million06/16/2025$12.81$12.69-0.94%$13.54$12.691,818 shs$106.19 million06/13/2025$13.15$12.81-2.59%$12.81$12.81166 shs$107.19 million06/12/2025$13.15$13.15$13.15$13.03769 shs$110.04 million06/11/2025$13.96$13.15-5.80%$13.15$13.03769 shs$110.04 million06/10/2025$13.96$13.96$13.99$12.921,355 shs$116.82 million Related Companies Aura Biosciences Stock Chart Astria Therapeutics Stock Chart DBV Technologies Stock Chart Atea Pharmaceuticals Stock Chart Annexon Stock Chart Aerovate Therapeutics Stock Chart Rocket Pharmaceuticals Stock Chart Monte Rosa Therapeutics Stock Chart Olema Pharmaceuticals Stock Chart Aardvark Therapeutics Stock Chart Receive EXOZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eXoZymes and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EXOZ) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s whole-government AI plans leakedThe New Elon Musk is officially stepping back from his day-to-day duties with DOGE. At least, that's the s...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eXoZymes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eXoZymes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.